SCHEMBL20012911

SCHEMBL20012911

CN1CCN(c2ccc(Nc3ncc(Br)c(-n4ccnc4)n3)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 12/20 0.57
▸ AURKA O14965 2/20 0.54
▸ CDK4 P11802 2/20 0.54
▸ FGFR1 P11362 1/20 0.52
▸ ALK Q9UM73 1/20 0.51
▸ KDR P35968 2/20 0.50
▸ TNK2 Q07912 1/20 0.50
▸ JAK2 O60674 2/20 0.49
▸ BRD4 O60885 1/20 0.49
▸ FGFR4 P22455 1/20 0.48
▸ INSR P06213 1/20 0.48
▸ CDK1 P06493 1/20 0.48
▸ PDGFRB P09619 1/20 0.48
▸ SRC P12931 1/20 0.48
▸ PDGFRA P16234 1/20 0.48
▸ FLT1 P17948 1/20 0.48
▸ FLT4 P35916 1/20 0.48
▸ CDK7 P50613 1/20 0.48
▸ NTRK2 Q16620 1/20 0.48
▸ MKNK1 Q9BUB5 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20012916 0.88 JAK2 (0.60) EGFRAURKACDK4ALKJAK2
SCHEMBL20012950 0.87 AURKA (0.54) EGFRAURKACDK4ALKJAK2
SCHEMBL20012912 0.87 ALK (0.62) EGFRAURKACDK4FGFR1ALK
SCHEMBL20012904 0.87 CDK4 (0.54) EGFRAURKACDK4FGFR1ALK
SCHEMBL20012983 0.85 EGFR (0.54) EGFRAURKACDK4ALKKDR
SCHEMBL20012926 0.80 MKNK1 (0.62) EGFRAURKACDK4ALKKDR
SCHEMBL20012909 0.79 PDGFRB (0.50) EGFRAURKACDK4FGFR1ALK
SCHEMBL14330683 0.78 ALK (0.64) EGFRFGFR1ALKKDRTNK2
SCHEMBL3274766 0.76 IGF1R (0.77) EGFRFGFR1ALKBRD4
SCHEMBL20012903 0.75 SYK (0.53) AURKACDK4JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018056621-A1 NOVEL IMIDAZOLYL PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER 재단법인 대구경북첨단의료산업진흥재단 2018-03-29 — — WO disclosed
Send feedback